简介: 【摘要】目的 探讨并分析安神补脑液治疗神经衰弱患者的临床疗效。方法 选取 2018年 12月~ 2019年 10月我院收治的患者 147例作为研究对象,将其随机分为试验组 74例和对照组 73例。对照组采用谷维素治疗,试验组采用安神补脑液治疗。比较两组的疗效和生活质量评分。结果 试验组的总有效率为 95.96%较对照组的 78.08%高,生活质量评分较对照组高,差异有统计学意义( P<0.05)。结论 安神补脑液治疗神经衰弱患者的疗效显著,值得推广。 【关键词】神经衰弱;安神补脑液;疗效 [Abstract] Objective To explore and analyze the clinical effect of Anshen Bunao liquid on neurasthenia. Methods 147 patients in our hospital from December 2018 to October 2019 were selected as the research objects, and they were randomly divided into experimental group (74 cases) and control group (73 cases). The control group was treated with oryzanol, and the experimental group was treated with Anshen Bunao liquid. The efficacy and quality of life scores were compared between the two groups. Results the total effective rate of the experimental group was 95.96%, which was higher than 78.08% of the control group, and the score of quality of life was higher than that of the control group (P < 0.05). Conclusion Anshen Bunao liquid has significant effect on neurasthenia patients, which is worthy of promotion.
简介:摘要:目的:探讨老年甲亢的临床表现、实验室检查特点及治疗。方法:回顾分析 40例 60岁以上老年甲亢的临床资料,在临床表现及实验室检查方面对接受治疗的老年甲亢进行分析,接受治疗的老年组与同等情况非老年的对照组进行比较。结果:老年甲亢多食、便次增多、烦躁易怒、甲状腺肿大、突眼、血管杂音较对照组少见,而纳差、便秘、抑郁、颈前黏液性水肿及糖尿病、高血压、房颤等合并症较对照组多见; T3、 T4升高不如对照组明显, FT3、 FT4升高与对照组无差异, 40例接受治疗的老年甲亢中一次性治愈 24例,无甲亢危象发生。结论:老年甲亢缺乏典型性, FT3、 FT4更有助于诊断,治疗是安全有效的。